Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up

NCT00001476 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Chronic Granulomatous Disease
Communicable Disease

Interventions

DRUG: Gene Therapy Method for CGD
DEVICE: Isolex 300i Magnetic Cell Selector

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)